1. Home
  2. List
Reference Patent

Reference - List

  • 103 Hits
  • Search Condition : Filter (MeSH = Pancreatic Neoplasms / pathology)
Species Resource Title
Human and Animal Cells PANC-1(RCB2095) Role of miR-30a-3p Regulation of Oncogenic Targets in Pancreatic Ductal Adenocarcinoma Pathogenesis.
Human and Animal Cells MIA Paca2(RCB2094) , PANC-1(RCB2095) FOXO3a Activation by HDAC Class IIa Inhibition Induces Cell Cycle Arrest in Pancreatic Cancer Cells.
Human and Animal Cells PANC-1(RCB2095) , MIA Paca2(RCB2094) Tenascin C in the Tumor-Nerve Microenvironment Enhances Perineural Invasion and Correlates With Locoregional Recurrence in Pancreatic Ductal Adenocarcinoma.
DNA material pCAG-HIVgp (RDB04394) , pCMV-VSV-G-RSV-Rev (RDB04393) SETDB1 Inhibits p53-Mediated Apoptosis and Is Required for Formation of Pancreatic Ductal Adenocarcinomas in Mice.
Human and Animal Cells PK-1(RCB1972) Treatment of primary and metastatic breast and pancreatic tumors upon intravenous delivery of a PRDM14-specific chimeric siRNA/nanocarrier complex.
Human and Animal Cells 1B2C6(RCB0795) , 1C3D3(RCB0796) Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice.
Human and Animal Cells PANC-1(RCB2095) Stomatin‑like protein 2 induces metastasis by regulating the expression of a rate‑limiting enzyme of the hexosamine biosynthetic pathway in pancreatic cancer.
Human and Animal Cells 409B2(HPS0076) Tumor-associated macrophages derived from cancer stem cells.
Human and Animal Cells PANC‐1(RCB2095) Glycosylation of MUC6 by α1,4-linked N-acetylglucosamine enhances suppression of pancreatic cancer malignancy.
Human and Animal Cells PANC-1(RCB2095) Structure-activity relationship and mechanistic study on guggulsterone derivatives; Discovery of new anti-pancreatic cancer candidate.
Human and Animal Cells PANC-1(RCB2095) , MIA Paca2(RCB2094) The novel driver gene ASAP2 is a potential druggable target in pancreatic cancer.
Human and Animal Cells PANC-1(RCB2095) , MIA Paca2(RCB2094) PCA-1/ALKBH3 contributes to pancreatic cancer by supporting apoptotic resistance and angiogenesis.
Human and Animal Cells PANC-1(RCB2095) Geranyl dihydrochalcones from Artocarpus altilis and their antiausteric activity.
Human and Animal Cells MIA Paca2(RCB2094) Pancreatic cancer cells express CD44 variant 9 and multidrug resistance protein 1 during mitosis.
Human and Animal Cells KP4(RCB1005) SETD5-Coordinated Chromatin Reprogramming Regulates Adaptive Resistance to Targeted Pancreatic Cancer Therapy.
Human and Animal Cells PANC-1(RCB2095) MK2461, a Multitargeted Kinase Inhibitor, Suppresses the Progression of Pancreatic Cancer by Disrupting the Interaction Between Pancreatic Cancer Cells and Stellate Cells.
Human and Animal Cells T3M-4(RCB1021) Glypican-1 identifies cancer exosomes and detects early pancreatic cancer.
DNA material CS-CDF-CG-PRE (RDB04379) , pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) Establishment of a long-term stable β-cell line and its application to analyze the effect of Gcg expression on insulin secretion.
Human and Animal Cells PK-8(RCB2700) Leucinostatin Y: A Peptaibiotic Produced by the Entomoparasitic Fungus Purpureocillium lilacinum 40-H-28.
Human and Animal Cells MIA Paca2(RCB2094) Experimental validation of stochastic microdosimetric kinetic model for multi-ion therapy treatment planning with helium-, carbon-, oxygen-, and neon-ion beams.